Literature DB >> 2667983

Response modification in carcinogenesis.

P A Cerutti1.   

Abstract

A major goal in multistep carcinogenesis research is the integration of recent findings obtained by sophisticated molecular-genetic and cytogenetic analysis of cancer into the more descriptive concepts of experimental pathology. It is proposed that the creation of a promotable cell in carcinogenic initiation requires a response modification to extracellular or intercellular signals. Different types of response modification can be distinguished: changes in the receptors for growth and differentiation factors and their cytoplasmic and nuclear signal transduction pathways; increased resistance of initiated cells to cytotoxic agents; alterations in junctional cell-to-cell communications. The challenge of a response-modified cell to an appropriate promoter results in its selection and clonal expansion, usually to a benign tumor. In addition, for malignancy, chromosomal changes are required that affect cellular functions that can play a role early or late in tumorigenesis. These concepts are illustrated with examples from oncogene research and oxidant promotion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2667983      PMCID: PMC1567556          DOI: 10.1289/ehp.898139

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  43 in total

1.  Oncogene-induced transformation of a rat embryo fibroblast cell line is enhanced by tumor promoters.

Authors:  W L Hsiao; T Wu; I B Weinstein
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

2.  Members of the src and ras oncogene families supplant the epidermal growth factor requirement of BALB/MK-2 keratinocytes and induce distinct alterations in their terminal differentiation program.

Authors:  B Weissman; S A Aaronson
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

3.  Inducible binding of a factor to the c-fos enhancer.

Authors:  R Prywes; R G Roeder
Journal:  Cell       Date:  1986-12-05       Impact factor: 41.582

Review 4.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

5.  Enhanced release of hydrogen peroxide and metabolites of arachidonic acid by macrophages from SENCAR mice following stimulation with phorbol esters.

Authors:  J G Lewis; D O Adams
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

6.  Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors.

Authors:  R Treisman
Journal:  Cell       Date:  1986-08-15       Impact factor: 41.582

7.  Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.

Authors:  E V Prochownik; J Kukowska
Journal:  Nature       Date:  1986 Aug 28-Sep 3       Impact factor: 49.962

8.  Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.

Authors:  E Dmitrovsky; W M Kuehl; G F Hollis; I R Kirsch; T P Bender; S Segal
Journal:  Nature       Date:  1986 Aug 21-27       Impact factor: 49.962

9.  c-myc and c-fos expression in differentiating mouse primary keratinocytes.

Authors:  G P Dotto; M Z Gilman; M Maruyama; R A Weinberg
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

10.  Induction of foci of altered, gamma-glutamyltranspeptidase-positive hepatocytes in carcinogen-treated rats fed a choline-deficient diet.

Authors:  M A Sells; S L Katyal; S Sell; H Shinozuka; B Lombardi
Journal:  Br J Cancer       Date:  1979-08       Impact factor: 7.640

View more
  2 in total

1.  In vitro models of carcinogenesis: expression of recessive genes by chromosomal mutations.

Authors:  J B Little
Journal:  Environ Health Perspect       Date:  1989-05       Impact factor: 9.031

2.  Nasal cytology in southwest metropolitan Mexico City inhabitants: a pilot intervention study.

Authors:  L Calderon-Garcidueñas; G Roy-Ocotla
Journal:  Environ Health Perspect       Date:  1993-06       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.